Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03088800 · ClinicalTrials.gov registry record · Phase 2
IBUPAP Study for Pain Management in Children
A Phase 2 study, sponsored by Antonios Likourezos.
- Completed
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
NCT03088800 is a Phase 2 study that has completed, run by Antonios Likourezos. The registered enrollment target is 90 participants.
The verdict
NCT03088800, a Phase 2 study, has completed, sponsored by Antonios Likourezos.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
Study Summary
Current literature supports ibuprofen and APAP are the most commonly used analgesics in the pediatric ED for acute traumatic/non-traumatic pain. However, the analgesic benefits of combination ibuprofen and APAP in this specific setting does not exist, but instead only as it applies to pediatric patients with postoperative pain. Thus, we have designed a double-blind, randomized, controlled clinical trial to evaluate analgesic efficacy, safety and feasibility of combination therapy to potentially broaden its clinical application in the pediatric ED. The investigators' hypothesize that combination oral ibuprofen and APAP therapy is superior to either drug alone and is an excellent analgesic modality for controlling acute traumatic/non-traumatic pain in the pediatric ED.
Interventions
- DRUG Ibuprofen
- DRUG APAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2018-04-30 |
| Est. Completion | 2020-07-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03088800
The ClinicalTrials.gov registry entry for NCT03088800 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Antonios Likourezos, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ibuprofen is the first listed.
NCT03088800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03088800 about?
NCT03088800 is a clinical study titled "IBUPAP Study for Pain Management in Children". Current literature supports ibuprofen and APAP are the most commonly used analgesics in the pediatric ED for acute traumatic/non-traumatic pain. However, the analgesic benefits of combination ibuprofen and APAP in this specific setting does not exist, but instead only as it applies to pediatric pati...
What is the current status of trial NCT03088800?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2018-04-30. Estimated completion is 2020-07-30.
What interventions are being tested in trial NCT03088800?
The interventions under investigation include: Ibuprofen (DRUG), APAP (DRUG).
Who is sponsoring clinical trial NCT03088800?
This trial is sponsored by Antonios Likourezos, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.